India Drug Infusion System Market Summary

As per Market Research Future analysis, the India Drug Infusion System Market Size was estimated at 493.5 USD Million in 2024. The India drug infusion-system market is projected to grow from 519.75 USD Million in 2025 to 872.8 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The India The India drug infusion-system market is poised for substantial growth. This growth is driven by technological advancements and an increasing demand for home healthcare solutions.

Technological advancements are reshaping the drug infusion-system market, enhancing efficiency and patient outcomes.
The largest segment in this market is the hospital-based infusion systems, while the fastest-growing segment is home healthcare infusion systems.
Regulatory support and initiatives are fostering a conducive environment for market expansion and innovation.
Rising demand for chronic disease management and increased investment in healthcare infrastructure are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size	493.5 (USD Million)
2035 Market Size	872.8 (USD Million)
CAGR (2025 - 2035)	5.32%

Major Players

Baxter International Inc (US), B. Braun Melsungen AG (DE), Medtronic plc (IE), Smiths Medical (US), Fresenius Kabi AG (DE), Terumo Corporation (JP), ICU Medical, Inc. (US), Halyard Health, Inc. (US), Zyno Medical LLC (US)

Our Impact

Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals

Partnering with 2000+ Global Organizations Each Year

30K+ Citations by Top-Tier Firms in the Industry

India Drug Infusion System Market Trends

The drug infusion-system market is currently experiencing notable growth. This growth is driven by advancements in technology and an increasing demand for precise medication delivery. Innovations in infusion pumps and related devices are enhancing patient safety and treatment efficacy. The integration of smart technology into these systems allows for better monitoring and management of drug administration. This is crucial in clinical settings. Furthermore, the rising prevalence of chronic diseases necessitates more sophisticated infusion solutions, thereby expanding the market's potential. Regulatory support and initiatives aimed at improving healthcare infrastructure are also contributing to the market's expansion. In addition, the drug infusion-system market is witnessing a shift towards home healthcare solutions. Patients increasingly prefer receiving treatment in the comfort of their homes, prompting manufacturers to develop portable and user-friendly devices. This trend aligns with the broader movement towards personalized medicine, where tailored treatment plans are becoming more common. As healthcare providers adapt to these changes, the market is likely to see further innovations that cater to the evolving needs of patients and healthcare professionals alike.

Technological Advancements

The drug infusion-system market is benefiting from rapid technological advancements. Innovations such as smart infusion pumps, which feature dose error reduction systems, are enhancing safety and accuracy in drug delivery. These devices often include connectivity features that allow for real-time monitoring and data sharing, which can improve patient outcomes and streamline clinical workflows.

Shift Towards Home Healthcare

There is a noticeable shift towards home healthcare solutions within the drug infusion-system market. Patients are increasingly opting for treatments at home, leading to a demand for portable and easy-to-use infusion devices. This trend reflects a broader movement towards personalized care, where treatment plans are tailored to individual patient needs.

Regulatory Support and Initiatives

Regulatory bodies are playing a crucial role in shaping the drug infusion-system market. Initiatives aimed at enhancing healthcare infrastructure and ensuring the safety and efficacy of infusion devices are fostering market growth. These regulations not only promote innovation but also ensure that patients receive high-quality care.

India Drug Infusion System Market Drivers

Growing Awareness of Patient Safety

There is a heightened awareness of patient safety and the importance of accurate drug delivery in India, which is influencing the drug infusion-system market. Healthcare professionals and institutions are increasingly recognizing the risks associated with manual drug administration, leading to a shift towards automated infusion systems. This trend is supported by various initiatives aimed at improving patient outcomes and reducing medication errors. The market for drug infusion systems is projected to grow by approximately 10% annually as hospitals and clinics adopt these technologies to enhance patient safety. The emphasis on safety and precision in drug delivery is likely to drive innovation within the drug infusion-system market, fostering the development of more sophisticated and reliable systems.

Expansion of Home Healthcare Services

The expansion of home healthcare services in India is likely to create new opportunities. This will benefit the drug infusion-system market. As more patients prefer receiving care at home, the demand for portable and user-friendly drug infusion systems is increasing. This trend is supported by the growing aging population and the rising incidence of chronic illnesses, which necessitate ongoing treatment. The home healthcare market is projected to grow at a rate of 20% annually, indicating a substantial opportunity for drug infusion systems designed for home use. This shift towards home-based care may significantly impact the drug infusion-system market, as it adapts to meet the needs of patients seeking convenient and effective treatment options.

Technological Integration in Healthcare

The integration of advanced technologies, such as IoT and AI, into healthcare practices is transforming the drug infusion-system market in India. These technologies enable real-time monitoring and data analysis, which can enhance the efficiency and effectiveness of drug delivery systems. Hospitals are increasingly adopting smart infusion pumps that can communicate with electronic health records, allowing for better tracking of medication administration. This technological shift is expected to propel the drug infusion-system market, with a projected growth rate of 14% over the next few years. The potential for improved patient outcomes and operational efficiency positions the drug infusion-system market as a key player in the evolving healthcare landscape.

Rising Demand for Chronic Disease Management

The increasing prevalence of chronic diseases in India, such as diabetes and cardiovascular disorders, drives the demand for effective treatment solutions. The drug infusion-system market is likely to benefit from this trend, as healthcare providers seek advanced methods to manage these conditions. According to recent estimates, chronic diseases account for approximately 60% of all deaths in India, highlighting the urgent need for efficient drug delivery systems. As healthcare facilities expand and improve, the adoption of drug infusion systems is expected to rise, potentially leading to a market growth rate of around 15% annually. This growing demand for chronic disease management solutions positions the drug infusion-system market as a critical component of India's healthcare landscape.

Increased Investment in Healthcare Infrastructure

India's government and private sector are significantly investing in healthcare infrastructure, which is likely to enhance the drug infusion-system market. The National Health Mission aims to improve healthcare access and quality, with a budget allocation of over $10 billion for various health initiatives. This investment is expected to facilitate the establishment of more hospitals and clinics equipped with modern medical technologies, including drug infusion systems. As healthcare facilities upgrade their equipment, the demand for advanced drug delivery systems is anticipated to rise. This trend may lead to a more robust drug infusion-system market, with an expected growth rate of 12% over the next few years, reflecting the increasing focus on quality healthcare delivery.

Market Segment Insights

By Product Type: Elastomeric infusion system (Largest) vs. Syringe infusion system (Fastest-Growing)

In the India drug infusion-system market, the market share distribution among different product types showcases a competitive landscape. The elastomeric infusion system holds a significant share, asserting its dominance in both hospitals and home care settings. In contrast, the syringe infusion system, while smaller in market share compared to elastomeric systems, is rapidly gaining traction due to its ease of use and versatility across various medical contexts. Growth trends within the product type segment reflect increasing patient-centric approaches and technological advancements. The syringe infusion system is witnessing the fastest growth in response to the rising demand for outpatient care services. Furthermore, advancements in design, safety features, and integration with digital health solutions are driving adoption rates across several product types, enhancing overall market competitiveness.

Elastomeric infusion system (Dominant) vs. Syringe infusion system (Emerging)

The elastomeric infusion system stands as the dominant product in the India drug infusion-system market, characterized by its self-contained features, ease of operation, and reliability for prolonged drug delivery. It is particularly favored in scenarios requiring extended therapy, offering benefits like reduced infection risk due to no need for continuous IV access. On the other hand, the syringe infusion system is emerging rapidly, appealing to healthcare providers for its compact design and flexibility in administering a variety of medications. With advancements that improve syringe precision and minimize errors, its popularity is surging, particularly in outpatient facilities. Both systems play vital roles, yet their distinct properties cater to diverse patient and clinical needs.

By Application: Oncology/Chemotherapy (Largest) vs. Diabetes (Fastest-Growing)

The market for drug infusion systems in the India drug infusion-system market exhibits a diverse distribution across various application segments. Oncology and chemotherapy are currently the largest segments, driven by the rising prevalence of cancer and the increasing adoption of advanced treatment options. Other significant segments include diabetes and analgesia, which also contribute notably to the overall market share, while pediatrics and nutrition hold smaller portions yet remain crucial for comprehensive patient care. Growth trends indicate that the diabetes segment is the fastest-growing due to the surge in diabetes cases linked to lifestyle changes, emphasizing the need for effective drug infusion solutions. Additionally, advancements in technology and increased focus on home care settings are further propelling the demand for these systems across the applications. The integration of smart technologies in infusion systems is also set to enhance treatment efficiency and patient monitoring, leading to expansive growth in this sector.

Oncology/Chemotherapy (Dominant) vs. Diabetes (Emerging)

Oncology and chemotherapy represent the dominant application in the India drug infusion-system market, primarily due to the increasing incidence of cancer and the evolving landscape of oncology treatments that require sophisticated drug delivery methods. These treatments necessitate precise dosing and monitoring, which drug infusion systems are well-equipped to provide. In contrast, the diabetes segment is emerging, driven by the alarming rise in diabetes prevalence and the need for effective management strategies. Innovations in infusion technology catering to diabetic patients, such as insulin pumps, are on the rise. Both segments underline a shift towards personalized and technology-driven healthcare solutions in the region, highlighting the importance of tailored approaches to meet the specific needs of patients.

By Mode of administration: Intravenous (Largest) vs. Subcutaneous (Fastest-Growing)

Among the modes of administration in the India drug infusion-system market, intravenous (IV) stands out as the dominant approach, holding the largest market share. Subcutaneous administration, however, is rapidly gaining traction, positioned as the fastest-growing segment within this market. The increasing prevalence of chronic diseases and the need for continuous medication delivery are driving this distribution, with healthcare providers increasingly favoring IV systems for their efficiency in acute care settings. The growth trends in this segment are influenced by advancements in technology and increasing patient preferences for less invasive options. The rise in outpatient care and home healthcare services further supports the shift towards subcutaneous methods, making them particularly appealing for long-term therapies. As patient awareness and acceptance grow, manufacturers are introduced innovative solutions that enhance comfort and convenience, propelling the segment's expansion.

Intravenous (Dominant) vs. Subcutaneous (Emerging)

The intravenous (IV) segment remains dominant in the India drug infusion-system market due to its ability to facilitate rapid drug delivery and is essential for emergency care scenarios. IV systems are critical for administering antibiotics, chemotherapy, and hydration therapies, making them indispensable in hospital settings. On the other hand, the subcutaneous segment is viewed as an emerging player, primarily driven by the increasing demand for self-administered medications and the convenience they offer. Subcutaneous methods are particularly favored for their simplicity and ease of use, suitable for chronic conditions where long-term treatment is necessary. As these systems evolve, we can expect advancements in device technology that further enhance patient compliance and their integration into diverse healthcare settings.

By End-user: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the India drug infusion-system market, hospitals hold the largest market share, attributed to their extensive infrastructure and constant demand for advanced healthcare solutions. Ambulatory surgical centers, while smaller in share, are rapidly gaining ground due to the rise in outpatient procedures and a shift towards more cost-effective healthcare delivery models. Diagnostic centers are also playing a significant role, though their market position is more niche compared to hospitals and surgical centers. The growth trends within this segment are largely driven by an increased focus on patient-centric care and technological advancements in drug infusion systems. Hospitals are investing in innovative infusion technologies to improve patient outcomes and streamline operations. On the other hand, ambulatory surgical centers are emerging as a preferred choice for many patients seeking efficiency and convenience, contributing to their rapid growth in the market, supported by favorable regulations and reimbursement policies.

Hospitals: Dominant vs. Ambulatory Surgical Centers: Emerging

Hospitals are the dominant players in the end-user segment, characterized by large-scale operations and a wide array of services offered, which include complex surgeries and critical care. They typically require advanced drug infusion systems to support a variety of procedures, leading to significant procurement volumes. Meanwhile, ambulatory surgical centers are categorized as emerging entities within this market. These facilities emphasize outpatient procedures and are half the size of traditional hospitals, representing a shift towards more efficient care models. Their growing presence is fueled by increasing patient preferences for minimally invasive procedures and cost efficiencies. As these centers enhance their operational capabilities, they continue to capture a larger share of the market, positioning themselves as key facilitators of modern healthcare.

Get more detailed insights about India Drug Infusion System Market

Request Free Sample

Key Players and Competitive Insights

The drug infusion-system market in India is characterized by a dynamic competitive landscape, driven by increasing healthcare demands and technological advancements. Major players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and Medtronic plc (IE) are strategically positioned to leverage innovation and regional expansion. Baxter International Inc (US) focuses on enhancing its product portfolio through continuous innovation, while B. Braun Melsungen AG (DE) emphasizes partnerships with local healthcare providers to strengthen its market presence. Medtronic plc (IE) is actively pursuing digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological integration and customer-centric solutions.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to varying customer needs while fostering healthy competition among established and emerging companies.

In October Baxter International Inc (US) announced a strategic partnership with a leading Indian healthcare provider to co-develop advanced infusion systems tailored for local market needs. This collaboration is expected to enhance Baxter's market penetration and align its offerings with the specific requirements of Indian healthcare facilities, thereby reinforcing its competitive edge in the region.

In September B. Braun Melsungen AG (DE) launched a new line of smart infusion pumps designed to improve medication safety and patient outcomes. This product introduction not only showcases B. Braun's commitment to innovation but also positions the company as a leader in the integration of technology within infusion systems, potentially attracting a broader customer base.

In August Medtronic plc (IE) expanded its manufacturing capabilities in India, investing approximately $50 million to enhance production efficiency and meet growing demand. This investment underscores Medtronic's long-term commitment to the Indian market and its strategy to localize production, which may lead to reduced costs and improved supply chain reliability.

As of November current competitive trends in the drug infusion-system market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and adapt to evolving market demands.

Key Companies in the India Drug Infusion System Market include

Industry Developments

The India Drug Infusion System Market has witnessed notable developments recently, particularly with increasing demand for advanced healthcare solutions. Fresenius Kabi expanded its portfolio significantly in September 2023 with the launch of new infusion devices tailored to improve patient safety and drug delivery efficiency. In August 2023, ICU Medical announced an uptick in revenue influenced by rising healthcare expenditures in India, indicating strong market potential.

Mergers and acquisitions have also been a theme, as in July 2023, Medtronic completed its acquisition of a regional player to enhance its infusion systems offerings. Market valuations are growing, with companies like Baxter International and Terumo Corporation investing in local manufacturing capabilities, resulting in improved accessibility and affordability of infusion devices across the nation.

Over the past 2-3 years, the market has seen substantial growth due to technological advancements, with hospitals increasingly opting for smart infusion systems. In November 2022, Johnson and Johnson unveiled an innovative drug imaging solution, which further solidified its presence in the Indian healthcare sector. With ongoing government initiatives to improve healthcare infrastructure, the Drug Infusion System Market in India is poised for sustained growth and modernization.

Future Outlook

India Drug Infusion System Market Future Outlook

The Drug Infusion System Market in India is projected to grow at a 5.32% CAGR from 2025 to 2035. This growth is driven by technological advancements and increasing healthcare demands.

New opportunities lie in:

Development of smart infusion pumps with IoT integration
Expansion of home healthcare infusion services
Partnerships with telehealth platforms for remote monitoring solutions

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

India Drug Infusion System Market End-user Outlook

Hospitals
Ambulatory Surgical Centers
Diagnostic centers
Others

India Drug Infusion System Market Application Outlook

Oncology/Chemotherapy
Diabetes
Analgesia
Nutrition
Hematology
Pediatrics
Others

India Drug Infusion System Market Product Type Outlook

Elastomeric infusion system
Disposable infusion system
Syringe infusion system
Peristaltic pump
Multi-channel pump
Patient-Controlled Analgesia (PCA) pump
Insulin pump
Implantable infusion system

India Drug Infusion System Market Mode of administration Outlook

Intravenous
Subcutaneous
Arterial
Epidural
Others

Report Scope

MARKET SIZE 2024	493.5(USD Million)
MARKET SIZE 2025	519.75(USD Million)
MARKET SIZE 2035	872.8(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.32% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Million
Key Companies Profiled	Baxter International Inc (US), B. Braun Melsungen AG (DE), Medtronic plc (IE), Smiths Medical (US), Fresenius Kabi AG (DE), Terumo Corporation (JP), ICU Medical, Inc. (US), Halyard Health, Inc. (US), Zyno Medical LLC (US)
Segments Covered	Product Type, Application, Mode of administration, End-user
Key Market Opportunities	Integration of smart technology in drug infusion systems enhances patient safety and operational efficiency.
Key Market Dynamics	Rising demand for advanced drug infusion systems driven by regulatory changes and technological innovations in healthcare.
Countries Covered	India

FAQs

What is the current valuation of the India drug infusion-system market?

The market valuation was $493.5 Million in 2024.

What is the projected market size for the India drug infusion-system market by 2035?

The market is expected to reach $872.8 Million by 2035.

What is the expected CAGR for the India drug infusion-system market during the forecast period 2025 - 2035?

The expected CAGR is 5.32% during the forecast period.

Which product type segment had the highest valuation in 2024?

The disposable infusion system segment had the highest valuation at $98.7 Million in 2024.

What are the key applications driving the India drug infusion-system market?

Key applications include oncology/chemotherapy, diabetes, analgesia, and nutrition.

Which end-user segment is projected to dominate the market by 2035?

The hospitals segment is projected to dominate, with a valuation of $200.0 - $350.0 Million.

Who are the leading players in the India drug infusion-system market?

Key players include Baxter International Inc, B. Braun Melsungen AG, and Medtronic plc.

What is the valuation range for the intravenous mode of administration in 2024?

The intravenous mode of administration had a valuation range of $200.0 - $350.0 Million in 2024.

How does the insulin pump segment perform in terms of valuation?

The insulin pump segment had a valuation of $49.35 Million in 2024, with potential growth.

What is the expected growth trend for the disposable infusion system segment by 2035?

The disposable infusion system segment is likely to grow from $98.7 Million in 2024 to a higher valuation by 2035.

Author

Author

Satyendra Maurya

Research Analyst

An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.

Co-Author

Garvit Vyas

Vice President - Operations

Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.

Get In Touch

Leave a Comment